The Division of Gastroenterology faculty and fellows annually maintain a wealth of scholarly activity, contributing a wealth of scientific knowledge and clinically significant results to their disciplines. Our division places a high priority on sharing their findings with the scientific community at large. In the last three years, the GI division has enumerated over 100 peer-reviewed publications and specialty meeting presentations. Please find below a representative sample of recent Division publications.
2020: Shen B, Kochhar G, Navaneethan U, Farraye FA, Schwartz DA, Lacucci M, Bernstein CN, Dryden G, Cross R, Bruining DH, Kobayashi T, Lukas M, Shergill A, Bortlik M, Lan N, Lukas M, Tang S, Kotze PG, Kiran RP, Dulai PS, El-Hachem S,
2020: Coelho-Prabhu N, Thakkar S, Mao R, Chen G, Zhang S, Suárez BG, Lama YG, Silverberg MS, Sandborn WJ. Practical guidelines on endoscopic treatment for Crohn’s disease strictures: a consensus statement from the Global Interventional Inflammatory Bowel Disease Group. Lancet Gastroenterol Hepatol. 2020; https://doi.org/10.1016/S2468-1253(19)30366-8.
2020: Thakkar SJ, Kochhar GS. Artificial intelligence for real-time detection of early esophageal cancer: another set of eyes to better visualize. Gastrointest Endosc. 2020;91:52-54.
2020: Isaacson M, Babich M. Drug-induced liver injury resources and reporting for the clinician. Clin Liver Dis. 2020;24:131-139. doi: 10.1016/j.cld.2019.09.010.
2020: Syed AR, Carleton NM, Horne Z, Dhawan A, Bedi G, Kochhar G, Morrissey S, Williams H, Atkinson D, Schiffman S, Monga D, Lupetin A, Kirichenko A, Mitre
M, Dhawan M, Kulkarni A, Thakkar S. Survival Trends for Resectable Pancreatic Cancer Using a Multidisciplinary Conference: the Impact of Post-operative Chemotherapy. J Gastrointest Cancer. 2020 Sep;51(3):836-843. doi: 10.1007/s12029-019-00303-z.
2020: Lara LF, Silva R, Thakkar S, Stanich PP, Mai D, Samarasena JB. Multicenter case series of patients with small-bowel angiodysplasias treated with a small-bowel radiofrequency ablation catheter. VideoGIE. 2020 Feb 6;5(4):162-167. doi: 10.1016/j.vgie.2019.11.014.
2020: Kochhar GS, Mohy-Ud-Din N, Grover A, Carleton N, Kulkarni A, Farah K, Dhawan M, Thakkar S. EUS-directed transgastric endoscopic retrograde cholangiopancreatography versus laparoscopic-assisted ERCP versus deep enteroscopy-assisted ERCP for patients with RYGB. Endosc Int Open. 2020 Jul;8(7):E877-E882. doi: 10.1055/a-1164-6282.
2020: Iacucci M, Cannatelli R, Labarile N, Mao R, Panaccione R, Danese, Kochhar GS, Ghosh S, Shen B. Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period. Lancet Gastroenterol Hepatol. 2020 Jun;5(6):598-606. doi: 10.1016/S2468-1253(20)30119-9.
2020: Dulai PS, Singh S, Casteele NV, Meserve J, Winters A, Chablaney S, Aniwan S, Shashi P, Kochhar G, Weiss A, Koliani-Pace JL, Gao Y, Boland BS, Chang JT, Faleck D, Hirten R, Ungaro R, Lukin D, Sultan K, Hudesman D, Chang S, Bohm M, Varma S, Fischer M, Shmidt E, Swaminath A, Gupta N, Rosario M, Jairath V, Guizzetti L, Feagan BG, Siegel CA, Shen B, Kane S, Loftus EV Jr, Sandborn WJ, Sands BE, Colombel JF, Lasch K, Cao C. Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis. Clin Gastroenterol Hepatol. 2020 Feb 13;S1542-3565(20)30174-9.
2020: Chen Y, Yu Q, Farraye FA, Kochhar GS, Bernstein CN, Navaneethan U, Wu K, Zhong J, Schwartz DA, Wu H, Zheng JJ, Iacucci M, Kiran RP, Shen B. Patterns of endoscopy during COVID-19 pandemic: a global survey of interventional inflammatory bowel disease practice. Intest Res. 2020 Jun 2. doi: 10.5217/ir.2020.00037.
2020: Mohan BP, Khan SR, Kassab LL, Ponnada S, Chandan S, Ali T, Dulai PS, Adler DG, Kochhar GS. High pooled performance of convolutional neural networks in computer-aided diagnosis of GI ulcers and/or hemorrhage on wireless capsule endoscopy images: a systematic review and meta-analysis. Gastrointest Endosc. 2020 Jul 25;S0016-5107(20)34633-2.
2020: Bohm M, Xu R, Zhang Y, Varma S, Fischer M, Kochhar G, Boland B, Singh S, Hirten R, Ungaro R, Shmidt E, Lasch K, Jairaith V, Hudesman D, Chang S, Lukin D, Swaminath A, Sands BE, Colombel JF, Kane S, Loftus EV Jr, Shen B, Siegel CA, Sandborn WJ, Dulai PS; VICTORY Collaboration. Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease. Aliment Pharmacol Ther. 2020 Jul 13. doi: 10.1111/apt.15921.
